Unknown

Dataset Information

0

TDP-43 is intercellularly transmitted across axon terminals.


ABSTRACT: Transactive response DNA-binding protein 43 kD (TDP-43) is an aggregation-prone prion-like domain-containing protein and component of pathological intracellular aggregates found in most amyotrophic lateral sclerosis (ALS) patients. TDP-43 oligomers have been postulated to be released and subsequently nucleate TDP-43 oligomerization in recipient cells, which might be the molecular correlate of the systematic symptom spreading observed during ALS progression. We developed a novel protein complementation assay allowing quantification of TDP-43 oligomers in living cells. We demonstrate the exchange of TDP-43 between cell somata and the presence of TDP-43 oligomers in microvesicles/exosomes and show that microvesicular TDP-43 is preferentially taken up by recipient cells where it exerts higher toxicity than free TDP-43. Moreover, studies using microfluidic neuronal cultures suggest both anterograde and retrograde trans-synaptic spreading of TDP-43. Finally, we demonstrate TDP-43 oligomer seeding by TDP-43-containing material derived from both cultured cells and ALS patient brain lysate. Thus, using an innovative detection technique, we provide evidence for preferentially microvesicular uptake as well as both soma-to-soma "horizontal" and bidirectional "vertical" synaptic intercellular transmission and prion-like seeding of TDP-43.

SUBMITTER: Feiler MS 

PROVIDER: S-EPMC4657165 | biostudies-literature | 2015 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications


Transactive response DNA-binding protein 43 kD (TDP-43) is an aggregation-prone prion-like domain-containing protein and component of pathological intracellular aggregates found in most amyotrophic lateral sclerosis (ALS) patients. TDP-43 oligomers have been postulated to be released and subsequently nucleate TDP-43 oligomerization in recipient cells, which might be the molecular correlate of the systematic symptom spreading observed during ALS progression. We developed a novel protein complemen  ...[more]

Similar Datasets

| S-EPMC6041977 | biostudies-literature
| S-EPMC8070438 | biostudies-literature
| S-SCDT-EMBOJ-2021-108443 | biostudies-other
| S-EPMC3406762 | biostudies-literature
| S-EPMC2478749 | biostudies-literature
| S-EPMC4478251 | biostudies-literature
| S-EPMC7040037 | biostudies-literature
| S-EPMC7888715 | biostudies-literature